文章名稱引用次數

• Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study179
• Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission84
• Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial78
• Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis72
• Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study58
• A global scientific strategy to cure hepatitis B54
• Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial53
• Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase multicentre trial48
• Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis44
• The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 201740